MedTrace Logo

Oral Curcumin Administration to Remit Metabolic Syndrome

NCT03795792 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2020-04-17

No results posted yet for this study

Summary

The metabolic syndrome consists of a set of risk factors that increases the probability to develop heart diseases and type 2 diabetes, two of the principal chronic diseases that affect Mexican population. The curcumin is a compound that is extracted from the root of a plant called Cúrcuma longa. There exists information that curcumin helps to diminish weight and the levels of blood glucose and blood fats. The hypothesis of this study is: that curcumin administration combined with diet and exercise remits the metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Curcumin

Will be provided in capsules

DIETARY_SUPPLEMENT

Hydrolyzed collagen

Will be provided in capsules.

Sponsors & Collaborators

  • Coordinación de Investigación en Salud, Mexico

    lead OTHER_GOV

Principal Investigators

  • Fernando Guerrero, PhD · Instituto Mexicano del Seguro Social

  • Luis Simental, PhD · Instituto Mexicano del Seguro Social

  • Gerardo Martínez, PhD · Instituto Mexicano del Seguro Social

  • Claudia Gamboa, PhD · Instituto Mexicano del Seguro Social

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-06
Primary Completion
2019-08-06
Completion
2019-12-06

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03795792 on ClinicalTrials.gov